Suppr超能文献

母胎医学会咨询系列第 51 号:剖宫产术血栓栓塞预防。

Society for Maternal-Fetal Medicine Consult Series #51: Thromboembolism prophylaxis for cesarean delivery.

机构信息

Society for Maternal-Fetal Medicine, 409 12 St. SW, Washington, DC 20024, USA.

出版信息

Am J Obstet Gynecol. 2020 Aug;223(2):B11-B17. doi: 10.1016/j.ajog.2020.04.032. Epub 2020 Apr 28.

Abstract

Venous thromboembolism is a major cause of maternal morbidity and mortality. The risk of venous thromboembolism is particularly elevated during the postpartum period and especially after cesarean delivery. There is considerable variation in the approach to prophylaxis of venous thromboembolism in pregnancy, including after cesarean delivery. This Consult discusses the different guidelines on prophylaxis of venous thromboembolism after cesarean delivery and provides recommendations based on the available evidence. The recommendations by the Society for Maternal-Fetal Medicine are as follows: (1) we recommend that all women who undergo cesarean delivery receive sequential compression devices starting before surgery and that the compression devices be used continuously until the patient is fully ambulatory (GRADE 1C); (2) we suggest that women with a previous personal history of deep venous thrombosis or pulmonary embolism who undergo cesarean delivery receive both mechanical (starting preoperatively and continuing until ambulatory) and pharmacologic (for 6 weeks postoperatively) prophylaxis (GRADE 2C); (3) we suggest that women with a personal history of an inherited thrombophilia (high-risk or low-risk) but no previous thrombosis who undergo cesarean delivery receive both mechanical (starting preoperatively and continuing until ambulatory) and pharmacologic (for 6 weeks postoperatively) prophylaxis (GRADE 2C); (4) we recommend the use of low-molecular-weight heparin as the preferred thromboprophylactic agent in pregnancy and the postpartum period (GRADE 1C); (5) when pharmacologic thromboprophylaxis is needed in pregnant women with class III obesity, we suggest the use of intermediate doses of enoxaparin (GRADE 2C); and (6) we recommend that each institution develop a patient safety bundle with an institutional protocol for venous thromboembolism prophylaxis among women who undergo cesarean delivery (Best Practice).

摘要

静脉血栓栓塞症是孕产妇发病率和死亡率的主要原因。静脉血栓栓塞症的风险在产后期间特别升高,尤其是在剖宫产之后。在妊娠期间,包括剖宫产之后,预防静脉血栓栓塞症的方法存在相当大的差异。本次咨询讨论了不同的剖宫产术后预防静脉血栓栓塞症的指南,并根据现有证据提供了建议。母胎医学学会的建议如下:(1)我们建议所有接受剖宫产的女性在手术前开始使用序贯压迫装置,并且在患者完全能够活动之前连续使用压迫装置(GRADE 1C);(2)我们建议既往有深静脉血栓形成或肺栓塞个人史的女性在接受剖宫产时接受机械(从术前开始并持续至可活动)和药物(术后 6 周)预防(GRADE 2C);(3)我们建议既往有遗传性易栓症(高危或低危)但无既往血栓形成史的女性在接受剖宫产时接受机械(从术前开始并持续至可活动)和药物(术后 6 周)预防(GRADE 2C);(4)我们建议在妊娠和产后期间使用低分子量肝素作为首选的血栓预防药物(GRADE 1C);(5)对于 Class III 肥胖的孕妇需要药物预防血栓形成时,我们建议使用中等剂量的依诺肝素(GRADE 2C);(6)我们建议每个机构为接受剖宫产的女性制定一个患者安全捆绑包,其中包括预防静脉血栓栓塞症的机构协议(最佳实践)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验